Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Menendez, A. Torres, Neumofail Group (Valencia, Barcelona, Group, Spain). Adherence to guidelines and clinical stability in community-acquired pneumonia. Eur Respir J 2004; 24: Suppl. 48, 1581

Member's Comments

No comment yet.

Related content which might interest you: Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 International Guideline concordance of empiric antibiotic use in community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018 Year: 2018 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: Guideline 2018 Year: 2019 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013 Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines Source: Eur Respir J 2003 Dec 01;22(6):876-882 Year: 2003 Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Validation of the ATS/IDSA guidelines for ICU-acquired pneumonia Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Clinical failure in community-acquired pneumonia Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Can CAP guideline adherence improve patient outcome in internal medicine departments? Source: Eur Respir J 2008; 32: 902-910 Year: 2008